Correspondence 0001193125-25-334252 from FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc.
Date: Dec. 29, 2025 · CIK: 0001958777 · Accession: 0001193125-25-334252
AI Filing Summary & Sentiment
File numbers found in text: 333-292407
Show Raw Text
CORRESP 1 filename1.htm CORRESP FIBROBIOLOGICS, INC. 455 E. Medical Center Blvd. Suite 300 Houston, Texas 77598 December 29, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes RE: FibroBiologics, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333- 292407 Dear Mr. Howes: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-292407) be accelerated by the Securities and Exchange Commission to 3:00 p.m. Washington D.C. time on December 30, 2025, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time. We request that we be notified of such effectiveness by a telephone call to me at 713.344.1482 and that such effectiveness also be confirmed in writing. Very truly yours, FibroBiologics, Inc. By: /s/ Ruben A. Garcia Name: Ruben A. Garcia Title: General Counsel